GRFS — Grifols SA
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1438569 ·
Last close
$8.63
Market Cap
$2.23B
52W High
$9.64
52W Low
$6.87
ADV30
701,450
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 2,040,000,000 | 807,000,000 | 394,000,000 | 162,000,000 | 20,281,000,000 | 486,000,000 | 12,038,000,000 |
| Jun 2026 | 1,874,000,000 | 705,000,000 | 329,000,000 | 155,000,000 | 20,090,000,000 | 513,000,000 | 12,110,000,000 |
| Mar 2026 | 1,700,000,000 | 620,000,000 | 249,000,000 | 73,000,000 | 20,078,000,000 | 702,000,000 | 12,231,000,000 |
| Dec 2025 | 1,981,660,000 | 686,841,000 | 275,377,000 | 98,250,000 | 19,712,000,000 | 801,000,000 | 12,109,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,117,864,000
Investing CF
$-538,321,000
Financing CF
$-737,176,000
CapEx
$-453,149,000
Dividends Paid
$-187,618,000
Buybacks
—
EPS Diluted TTM
$0.76
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$390,000,000
Inventory
$3,469,000,000
Receivables
$1,079,000,000
ST Investments
$209,000,000
EBIT TTM
$1,188,087,000
Pretax Income TTM
$708,096,000
Interest Exp TTM
$558,421,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$7,421,000,192
EBITDA
$1,645,230,976
Free Cash Flow
$572,923,392
Enterprise Value
$21,529,769,984
Total Cash
$537,000,000
Total Debt
$9,356,000,256
Shares Out
258,223,442
Trailing EPS
$0.77
Book Value
$4.72
ROE
6.9%
ROA
4.2%
Div Yield
3.73%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 7,524,000,000 | 1,251,000,000 | 402,000,000 | 19,712,000,000 | 12,109,000,000 | 5,271,000,000 | 1,047,000,000 |
| Dec 2024 | 7,212,000,000 | 1,155,000,000 | 157,000,000 | 21,405,000,000 | 12,799,000,000 | 5,883,000,000 | 902,000,000 |
| Dec 2023 | 6,592,000,000 | 718,000,000 | 42,000,000 | 20,992,103,000 | 13,478,408,000 | 5,368,376,000 | 217,000,000 |
| Dec 2022 | 6,063,967,000 | 678,958,000 | 185,035,000 | 21,229,584,000 | 13,253,455,000 | 5,648,523,000 | -1,427,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.44
Max Pain — expiry 2026-12-18
max pain strike: $8.00 · spot: $8.47 · call oi: 2,343 · put oi: 1,579
Expected Move to 2026-12-18:
±$1.08
(12.69%) —
implied range
$7.40 –
$9.55
· ATM straddle on $8.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LKFT | Lakefront Biotherapeutics NV | $2.25B | $34.39 | — |
| PHVS | Pharvaris N.V. | $2.27B | $32.28 | — |
| PRGO | PERRIGO Co plc | $2.19B | $15.76 | — |
| PBH | Prestige Consumer Healthcare Inc. | $2.29B | $48.22 | — |
| GLPGF | Lakefront Biotherapeutics NV | $2.30B | $35.15 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Advance Sharply in Wednesday Trading
2026-11-04 16:13 · Yahoo
Grifols (BME:GRF) Stock Price Trails Q3 Results As Debt Questions Linger
2026-11-03 19:11 · Yahoo
Grifols Beats Q3 Revenue Forecasts as Immunoglobulin Demand Supports Profit Growth
2026-11-03 11:17 · Yahoo
Grifols SA (GRFS) Q3 2026 Earnings Call Highlights: Biopharma Growth Accelerates as Margin ...
2026-11-03 05:03 · Yahoo
Grifols (GRFS) Q3 2026 Earnings Call Transcript
2026-11-03 03:58 · Yahoo
Grifols Q3 Earnings Call Highlights
2026-11-02 20:12 · Yahoo
Grifols Q3 revenue exceeds estimates as immunoglobulin sales drive growth
2026-11-02 18:20 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
2026-11-02 16:16 · Yahoo
Grifols (BME:GRF) Stock Still Looks Cheap Based On Current Earnings
2026-10-27 06:07 · Yahoo
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
2026-10-26 15:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.